1. Home
  2. RGEN vs EXLS Comparison

RGEN vs EXLS Comparison

Compare RGEN & EXLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$117.04

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Logo ExlService Holdings Inc.

EXLS

ExlService Holdings Inc.

HOLD

Current Price

$30.32

Market Cap

4.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGEN
EXLS
Founded
1981
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
4.8B
IPO Year
1995
2004

Fundamental Metrics

Financial Performance
Metric
RGEN
EXLS
Price
$117.04
$30.32
Analyst Decision
Buy
Strong Buy
Analyst Count
12
5
Target Price
$167.67
$46.80
AVG Volume (30 Days)
817.5K
1.9M
Earning Date
05-05-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
286.96
27.27
EPS
0.86
1.54
Revenue
$141,236,000.00
$2,087,679,000.00
Revenue This Year
$14.30
$12.61
Revenue Next Year
$14.52
$10.55
P/E Ratio
$131.21
$19.75
Revenue Growth
35.10
13.56
52 Week Low
$109.50
$26.94
52 Week High
$175.77
$48.79

Technical Indicators

Market Signals
Indicator
RGEN
EXLS
Relative Strength Index (RSI) 42.86 44.17
Support Level $111.29 $28.91
Resistance Level $131.93 $31.50
Average True Range (ATR) 6.15 0.86
MACD -0.27 0.07
Stochastic Oscillator 23.16 42.66

Price Performance

Historical Comparison
RGEN
EXLS

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

About EXLS ExlService Holdings Inc.

ExlService Holdings Inc. is a data analytics and digital operations company that provides data and AI-led solutions and technology-enabled services to clients across industries. The company has four reportable segments. The Insurance segment provides services such as claims management, underwriting support, and analytics solutions. The Healthcare and Life Sciences segment offers data-driven solutions and services to healthcare payers, providers, and life sciences organizations. The Banking, Capital Markets and Diversified Industries segment delivers solutions across financial services and other industries. The International Growth Markets segment focuses on providing data, AI, and digital operations services to clients outside North America.

Share on Social Networks: